Product
Type 2 Diabetes Therapeutics
PHARMACEUTICAL
byBrighthaven Ventures, LLC
United States (US)
ABOUT THE PRODUCT
Lead development program for a novel therapeutic targeting Type 2 Diabetes, currently in Phase 2 clinical trials.
Information is owner-confirmed
Last updated 23 hours ago
Price range